Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A renaissance in low-level laser (light) therapy – LLLT

A renaissance in low-level laser (light) therapy – LLLT DOI 10.1515/plm-2012-0044Photon Lasers Med 2012; 1(4): 231­234 Editorial Renaissance der Low-Level-Laser(Licht)therapie ­ LLLT This special issue on low-level laser (light) therapy (LLLT) has been assembled by soliciting individual contributions from a broad spectrum of specialists in the field throughout the world. LLLT also known as photobiomodulation, is the drug-free, non-invasive and safe (FDA approved) clinical application of light ­ usually produced by low to mid power lasers or light emitting diodes (LED) with a power output in the range of 1­500 mW ­ to a patient to promote tissue regeneration and healing, reduce inflammation and relieve pain. The light is typically of narrow spectral range (1­40 nm bandwidth), in the visible (red) or near infrared (NIR) spectrum (600­1000 nm), and achieves an average power density (irradiance) between 1 mW/cm2 and 5 W/cm2 [1]. The reason why the technique is termed "lowlevel" or "cold laser" therapy is that the optimum level of energy density (J/cm2) delivered to the tissues is low when compared to other forms of laser therapy such as those used for ablation, cutting, and thermally coagulating tissue. In general, the power densities used for LLLT are lower than those needed to produce heating of tissue (i.e., http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Photonics & Lasers in Medicine de Gruyter

A renaissance in low-level laser (light) therapy – LLLT

Loading next page...
 
/lp/de-gruyter/a-renaissance-in-low-level-laser-light-therapy-lllt-tXrEB8EvqQ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
Copyright © 2012 by the
ISSN
2193-0635
eISSN
2193-0643
DOI
10.1515/plm-2012-0044
Publisher site
See Article on Publisher Site

Abstract

DOI 10.1515/plm-2012-0044Photon Lasers Med 2012; 1(4): 231­234 Editorial Renaissance der Low-Level-Laser(Licht)therapie ­ LLLT This special issue on low-level laser (light) therapy (LLLT) has been assembled by soliciting individual contributions from a broad spectrum of specialists in the field throughout the world. LLLT also known as photobiomodulation, is the drug-free, non-invasive and safe (FDA approved) clinical application of light ­ usually produced by low to mid power lasers or light emitting diodes (LED) with a power output in the range of 1­500 mW ­ to a patient to promote tissue regeneration and healing, reduce inflammation and relieve pain. The light is typically of narrow spectral range (1­40 nm bandwidth), in the visible (red) or near infrared (NIR) spectrum (600­1000 nm), and achieves an average power density (irradiance) between 1 mW/cm2 and 5 W/cm2 [1]. The reason why the technique is termed "lowlevel" or "cold laser" therapy is that the optimum level of energy density (J/cm2) delivered to the tissues is low when compared to other forms of laser therapy such as those used for ablation, cutting, and thermally coagulating tissue. In general, the power densities used for LLLT are lower than those needed to produce heating of tissue (i.e.,

Journal

Photonics & Lasers in Medicinede Gruyter

Published: Nov 1, 2012

There are no references for this article.